<DOC>
	<DOC>NCT00290134</DOC>
	<brief_summary>The purpose of this study is to determine whether one or more fispemifene dose regimens are more effective than placebo in the treatment of hypogonadism in older men.</brief_summary>
	<brief_title>A Preliminary Clinical Study to Evaluate Fispemifene in the Treatment of Hypogonadism</brief_title>
	<detailed_description />
	<mesh_term>Hypogonadism</mesh_term>
	<mesh_term>Tamoxifen</mesh_term>
	<criteria>Total testosterone level &lt;240 ng/dL Serum LH and FSH levels within normal limits Elevated prolactin Evidence of Benign Prostatic Hypertrophy History of or current breast cancer, prostate cancer, abnormal DRE or elevated PSA or any other malignancy Clinically significant endocrine/metabolic or cardiovascular disease Significant polycythemia</criteria>
	<gender>Male</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2008</verification_date>
	<keyword>Hypogonadism</keyword>
	<keyword>Testosterone</keyword>
</DOC>